Puration Inc (OTCMKTS:PURA) Targets $4 Million Sales For CBD Infused Beverages And Complements Aurora Cannabis Inc (NYSE:ACB) For Its Strategy To Focus On Legal Hemp-Derived CBD in The US

Puration Inc (OTCMKTS:PURA) has given a pat on the back of Aurora Cannabis Inc (NYSE:ACB) for its decision to focus on the legal hemp-derived CBD in the US. The company has already established its name in the sports market of the US.

Aurora Cannabis enters a pact with UFC

Aurora Cannabis has already signed an accord with Ultimate Fighting Championship (UFC) to advance clinical research on athlete wellness and recovery and hemp-derived cannabidiol products. It is a multi-year, exclusive, and multi-million dollar partnership. This pact helps to expedite the development of CBD products and focus on education. UFC broadcasts its program to more than 170 nations worldwide. It commands viewership of 300 million. More than 1 billion households watch programmes in 40 different languages.

Aurora plans to use CBD to treat sports-related pains and helps quick recovery. On the other hand, PURA focuses on sports nutrition market with its EVERx CBD Sports Water. The brand worked with Cee Jay Hamilton and Juliana Penna, prominent fighters of the UFC. PURA has an exclusive license to the patented cannabis extraction process of Kali-Extracts. Further, it also gets access to R&D on various applications of CBD. The company has participated in Arnold Sports Festival to market its EVERx CBD Sports water worldwide.

PURA will launch a campaign this week in Barcelona, Spain to market its EVERx CBD products in Europe. The company views the strategy of Aurora Cannabis as the validation of its long term strategy.

PURA plans $4 million worth CBD beverages

The production of CBD Beverages at the facility of PURA exceeded $1 million in 2018. PURA has already produced more than $1 million worth CBD in H1 of 2019. The company plans to manufacture CBD beverages worth $4 million in 2019.

According to Goldman Small Cap Research, investors indulged in the speculative buy of PURA and set a target of $0.25 PPS. It is on the background of the announcement of market survey results of CBD infused beverages and the expansion plans of these beverages. PURA is poised in the market with its CBD beverages. It is on the proposed expansion of CBD Infused tea that has anti-inflammatory and anti-anxiety properties.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.

Leave a Reply

Your email address will not be published. Required fields are marked *

Aurora Cannabis Inc (NYSE:ACB) Announces Impairment Charges Of $752.79 Million: Michael Singer Becomes Interim CEO: Downsizes Workforce UFC And Aurora Cannabis Inc (NYSE:ACB) To Work Jointly To Improve Safety And Wellness Of Athletes Using Advanced CBD Products Aurora Cannabis Inc (NYSE:ACB) Wins A Second Order From Luxembourg Healthy Ministry To Supply Medical Cannabis To de la Pharmacie et des Medicaments

Pin It on Pinterest